- Twist Bioscience Corporation (TWST, Financial) has accelerated the turnaround time for its gene fragments to just two business days.
- Pricing starts at seven cents per base pair with no hidden fees, offering flexibility and transparency.
- Twist's gene fragments are compatible with all downstream cloning methods, catering to a wide range of applications.
Twist Bioscience Corporation (TWST), a key player in the life sciences segment, has announced an expedited turnaround time for all its gene fragments, now starting at just two business days. This enhanced service is applicable regardless of the gene fragments' length, volume, configuration, or delivery format, reinforcing Twist's commitment to meeting customer needs with efficiency and reliability.
The South San Francisco-based company offers competitive pricing at seven cents per base pair across all configurations, ensuring there are no hidden fees involved. This transparency underscores Twist's aim to provide affordable and flexible solutions for researchers in various fields including protein engineering, antibody discovery, and diagnostic assays.
Twist's gene fragments are available in customizable formats such as tubes, plates, normalization, and resuspension, maintaining the fast delivery times without additional costs. By eliminating the fee for removing adaptors, Twist ensures its offerings are user-friendly and economically viable, further aided by the industry's lowest error rate of 1:7500.
With a market capitalization of $2.21 billion, Twist Bioscience continues to innovate and leverage its automated workflow and scalable infrastructure, facilitating the rapid synthesis and delivery of synthetic DNA globally. This positions the company as a pivotal partner for researchers aiming for precision and efficiency in their scientific endeavors.